Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Granulocyte macrophage colony-stimulating factor auto-antibodies and disease relapse in inflammatory bowel disease.

Däbritz J, Bonkowski E, Chalk C, Trapnell BC, Langhorst J, Denson LA, Foell D.

Am J Gastroenterol. 2013 Dec;108(12):1901-10. doi: 10.1038/ajg.2013.360. Epub 2013 Oct 22.

PMID:
24145675
2.

Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease.

Gathungu G, Kim MO, Ferguson JP, Sharma Y, Zhang W, Ng SM, Bonkowski E, Ning K, Simms LA, Croft AR, Stempak JM, Walker N, Huang N, Xiao Y, Silverberg MS, Trapnell B, Cho JH, Radford-Smith GL, Denson LA.

Inflamm Bowel Dis. 2013 Jul;19(8):1671-80. doi: 10.1097/MIB.0b013e318281f506.

3.

Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease.

Nylund CM, D'Mello S, Kim MO, Bonkowski E, Däbritz J, Foell D, Meddings J, Trapnell BC, Denson LA.

J Pediatr Gastroenterol Nutr. 2011 May;52(5):542-8. doi: 10.1097/MPG.0b013e3181fe2d93.

PMID:
21502824
4.

Improving relapse prediction in inflammatory bowel disease by neutrophil-derived S100A12.

Däbritz J, Langhorst J, Lügering A, Heidemann J, Mohr M, Wittkowski H, Krummenerl T, Foell D.

Inflamm Bowel Dis. 2013 May;19(6):1130-8. doi: 10.1097/MIB.0b013e318280b1cd.

PMID:
23377171
5.

Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease.

Han X, Uchida K, Jurickova I, Koch D, Willson T, Samson C, Bonkowski E, Trauernicht A, Kim MO, Tomer G, Dubinsky M, Plevy S, Kugathsan S, Trapnell BC, Denson LA.

Gastroenterology. 2009 Apr;136(4):1261-71, e1-3. doi: 10.1053/j.gastro.2008.12.046. Epub 2008 Dec 24.

PMID:
19230854
6.

Increased prevalence of luminal narrowing and stricturing identified by enterography in pediatric Crohn's disease patients with elevated granulocyte-macrophage colony stimulating factor autoantibodies.

Dykes DM, Towbin AJ, Bonkowski E, Chalk C, Bezold R, Lake K, Kim MO, Heubi JE, Trapnell BC, Podberesky DJ, Denson LA.

Inflamm Bowel Dis. 2013 Sep;19(10):2146-54. doi: 10.1097/MIB.0b013e31829706e0.

7.

Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes.

Bonneau J, Dumestre-Perard C, Rinaudo-Gaujous M, Genin C, Sparrow M, Roblin X, Paul S.

Autoimmun Rev. 2015 Mar;14(3):231-45. doi: 10.1016/j.autrev.2014.11.004. Epub 2014 Nov 13. Review.

PMID:
25462578
8.

Familial Association of Granulocyte-Macrophage Colony Stimulating Factor Autoantibodies in Inflammatory Bowel Disease.

Wright SS, Trauernicht A, Bonkowski E, McCall CA, Maier EA, Bezold R, Lake K, Chalk C, Trapnell BC, Kim MO, Kugathasan S, Denson LA.

J Pediatr Gastroenterol Nutr. 2017 Dec 5. doi: 10.1097/MPG.0000000000001851. [Epub ahead of print]

PMID:
29216019
9.

Paediatric Crohn disease patients with stricturing behaviour exhibit ileal granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody production and reduced neutrophil bacterial killing and GM-CSF bioactivity.

Jurickova I, Collins MH, Chalk C, Seese A, Bezold R, Lake K, von Allmen D, Frischer JS, Falcone RA, Trapnell BC, Denson LA.

Clin Exp Immunol. 2013 Jun;172(3):455-65. doi: 10.1111/cei.12076.

10.

Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.

Walkiewicz D, Werlin SL, Fish D, Scanlon M, Hanaway P, Kugathasan S.

Inflamm Bowel Dis. 2008 May;14(5):669-73. doi: 10.1002/ibd.20376.

PMID:
18240279
11.

[Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].

Xu KF, Chen Y, Guo ZJ, Zhu YJ.

Zhonghua Jie He He Hu Xi Za Zhi. 2004 Dec;27(12):824-8. Chinese.

PMID:
15730782
13.

Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn's disease.

Gathungu G, Zhang Y, Tian X, Bonkowski E, Rowehl L, Krumsiek J, Nix B, Chalk C, Trapnell B, Zhu W, Newberry R, Denson L, Li E.

World J Gastroenterol. 2018 Feb 7;24(5):623-630. doi: 10.3748/wjg.v24.i5.623.

14.
15.

Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.

Mooiweer E, Severs M, Schipper ME, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.

J Crohns Colitis. 2015 Jan;9(1):50-5. doi: 10.1093/ecco-jcc/jju003. Epub 2014 Nov 26.

PMID:
25518048
16.

Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in Inflammatory Bowel disease.

Ina K, Kusugami K, Hosokawa T, Imada A, Shimizu T, Yamaguchi T, Ohsuga M, Kyokane K, Sakai T, Nishio Y, Yokoyama Y, Ando T.

J Gastroenterol Hepatol. 1999 Jan;14(1):46-53.

PMID:
10029277
17.

Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.

Saijo T, Chen J, Chen SC, Rosen LB, Yi J, Sorrell TC, Bennett JE, Holland SM, Browne SK, Kwon-Chung KJ.

MBio. 2014 Mar 18;5(2):e00912-14. doi: 10.1128/mBio.00912-14.

18.

Cytokine refacing effect reduces granulocyte macrophage colony-stimulating factor susceptibility to antibody neutralization.

Heinzelman P, Carlson SJ, Cox GN.

Protein Eng Des Sel. 2015 Oct;28(10):461-6. doi: 10.1093/protein/gzv019. Epub 2015 Apr 7.

19.

Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations.

Svenson M, Hansen MB, Ross C, Diamant M, Rieneck K, Nielsen H, Bendtzen K.

Blood. 1998 Mar 15;91(6):2054-61.

20.

Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis.

D'Mello S, Trauernicht A, Ryan A, Bonkowski E, Willson T, Trapnell BC, Frank SJ, Kugasathan S, Denson LA.

Inflamm Bowel Dis. 2012 Feb;18(2):236-45. doi: 10.1002/ibd.21689. Epub 2011 Feb 18.

Supplemental Content

Support Center